Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Depreciation and Depletion (2017 - 2026)

Rockwell Medical filings provide 9 years of Depreciation and Depletion readings, the most recent being $400000.0 for Q4 2025.

  • On a quarterly basis, Depreciation and Depletion changed 0.0% to $400000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.6 million, a 0.0% change, with the full-year FY2025 number at $1.6 million, changed 0.0% from a year prior.
  • Depreciation and Depletion hit $400000.0 in Q4 2025 for Rockwell Medical, roughly flat from $400000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $400000.0 in Q3 2023 to a low of $100000.0 in Q3 2021.
  • Median Depreciation and Depletion over the past 5 years was $300000.0 (2021), compared with a mean of $278400.0.
  • Biggest five-year swings in Depreciation and Depletion: crashed 50.0% in 2021 and later soared 300.0% in 2023.
  • Rockwell Medical's Depreciation and Depletion stood at $168000.0 in 2021, then grew by 19.05% to $200000.0 in 2022, then skyrocketed by 100.0% to $400000.0 in 2023, then changed by 0.0% to $400000.0 in 2024, then changed by 0.0% to $400000.0 in 2025.
  • The last three reported values for Depreciation and Depletion were $400000.0 (Q4 2025), $400000.0 (Q3 2025), and $400000.0 (Q2 2025) per Business Quant data.